PARMAR KUSH

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
24 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
PARMAR KUSH's trades of Entrada Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-18 2025-11-14
S Sale
70,745 -40.0%
304.41
US$250,459 		70,745 -40.0% 304.41 US$250,459
2025-07-11 2025-07-09
S Sale
28,048 -1.3%
295.93
US$1,480,103 		28,048 -1.3% 295.93 US$1,480,103
2025-07-11 2025-07-09
S Sale
34,854 -39.4%
138.69
US$1,816,347 		34,854 -39.4% 138.69 US$1,816,347
2025-07-01 2025-07-01
S Sale
6,422 -0.6%
7.12
US$45,741 		6,422 -0.6% 7.12 US$45,741
2025-07-01 2025-07-01
S Sale
18,578 -0.6%
7.12
US$132,324 		18,578 -0.6% 7.12 US$132,324
2025-07-01 2025-06-30
S Sale
6,422 -0.6%
6.81
US$43,751 		6,422 -0.6% 6.81 US$43,751
2025-07-01 2025-06-30
S Sale
18,578 -0.6%
6.81
US$126,566 		18,578 -0.6% 6.81 US$126,566
2025-07-01 2025-06-27
S Sale
19,265 -1.7%
6.91
US$133,121 		19,265 -1.7% 6.91 US$133,121
2025-07-01 2025-06-27
S Sale
55,735 -1.7%
6.91
US$385,129 		55,735 -1.7% 6.91 US$385,129
2023-03-09 2023-03-07
US Rallybio Corp (RLYB)
S Sale
100,000 -4.0%
8.20
US$820,000 		100,000 -4.0% 8.20 US$820,000
2022-06-07 2022-06-03
US Rallybio Corp (RLYB)
S Sale
50,329 -3.9%
12.50
US$629,112 		50,329 -3.9% 12.50 US$629,112
2022-06-07 2022-06-03
US Rallybio Corp (RLYB)
S Sale
99,671 -3.9%
12.50
US$1,245,888 		99,671 -3.9% 12.50 US$1,245,888
2022-05-25 2022-05-23
US Rallybio Corp (RLYB)
S Sale
33,553 -2.5%
13.00
US$436,189 		33,553 -2.5% 13.00 US$436,189
2022-05-25 2022-05-23
US Rallybio Corp (RLYB)
S Sale
66,447 -2.5%
13.00
US$863,811 		66,447 -2.5% 13.00 US$863,811
2022-02-10 2022-02-08
US Rallybio Corp (RLYB)
S Sale
70,461 -5.0%
13.05
US$919,516 		70,461 -5.0% 13.05 US$919,516
2022-02-10 2022-02-08
US Rallybio Corp (RLYB)
S Sale
139,539 -5.0%
13.05
US$1,820,984 		139,539 -5.0% 13.05 US$1,820,984
2021-11-18 2021-11-16
S Sale
91,836 -4.9%
15.30
US$1,405,091 		91,836 -4.9% 15.30 US$1,405,091
2021-11-18 2021-11-16
S Sale
238,870 -4.9%
15.30
US$3,654,711 		238,870 -4.9% 15.30 US$3,654,711
2021-11-05 2021-11-02
B Purchase
250,000 +28.3%
20.00
US$5,000,000 		250,000 +28.3% 20.00 US$5,000,000
2021-08-04 2021-08-02
US Rallybio Corp (RLYB)
B Purchase
615,384 +77.8%
13.00
US$7,999,992 		615,384 +77.8% 13.00 US$7,999,992
2021-02-09 2021-02-09
B Purchase
444,444 +31.4%
18.00
US$7,999,992 		444,444 +31.4% 18.00 US$7,999,992
2021-02-09 2021-02-09
B Purchase
111,111 +2.4%
18.00
US$1,999,998 		111,111 +2.4% 18.00 US$1,999,998
2020-12-28 2020-12-22
US Q32 Bio Inc (QTTB)
S Sale
20,000 -9.9%
12.82
US$256,400 		20,000 -9.9% 12.82 US$256,400
2020-12-28 2020-12-22
US Q32 Bio Inc (QTTB)
S Sale
480,000 -9.9%
12.82
US$6,153,600 		480,000 -9.9% 12.82 US$6,153,600
2020-12-16 2020-12-14
US Q32 Bio Inc (QTTB)
S Sale
13,703 -6.4%
11.88
US$162,792 		13,703 -6.4% 11.88 US$162,792
2020-12-16 2020-12-14
US Q32 Bio Inc (QTTB)
S Sale
6,297 -2.8%
13.06
US$82,244 		6,297 -2.8% 13.06 US$82,244
2020-12-16 2020-12-14
US Q32 Bio Inc (QTTB)
S Sale
328,862 -6.4%
11.88
US$3,906,881 		328,862 -6.4% 11.88 US$3,906,881
2020-12-16 2020-12-14
US Q32 Bio Inc (QTTB)
S Sale
151,138 -2.8%
13.06
US$1,973,998 		151,138 -2.8% 13.06 US$1,973,998
2020-07-02 2020-06-30
US Akouos Inc (AKUS)
B Purchase
294,117 +36.8%
17.00
US$4,999,989 		294,117 +36.8% 17.00 US$4,999,989
2019-05-20 2019-05-16
US Q32 Bio Inc (QTTB)
S Sale
24,600 -10.0%
21.47
US$528,162 		24,600 -10.0% 21.47 US$528,162
2019-05-20 2019-05-16
US Q32 Bio Inc (QTTB)
S Sale
590,400 -10.0%
21.47
US$12,675,888 		590,400 -10.0% 21.47 US$12,675,888